Clinical Trial Imaging Market

Clinical Trial Imaging Market 2022 Analysis of Key Trends, Industry Dynamics and Future Growth 2028 with Top Countries Data.

Clinical Trial Imaging Market Size was Valued at USD 963 Million in 2020 and is Projected to Reach USD 1,518 Million by 2028.

Global Clinical Trial Imaging Market is growing at a CAGR of 5.9% from 2021 to 2028.Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

Clinical trials are an important part of the drug development process. However, the cost of conducting clinical trials has increased in recent years. Therefore, clinical trial imaging is emerging as an alternative measure that can help reduce the cost of the drug trial and thus improve the timeline of clinical trials. Increasing the use of the technology along with enhanced power of computing is boosting the usage of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol offers standardized methods as well as imaging procedures with uniform procedures that can be implemented to attain precise and statistical endpoints in clinical trials.

Request a free sample copy or view report summary: https://healthcaremarketreports.com/sample-request/clinical-trial-imaging-market/48/

 Global Clinical Trial Imaging Market: Top Key Players

Cardiovascular Imaging Technologies, LLC

Radiant Sage LLC

Biotelemetry, Inc.

Intrinsic Imaging LLC

Ixico PLC

Icon PLC

Worldcare Clinical, LLC

Biomedical Systems Corporation

Parexel International Corporation

Bioclinica, Inc.

By Types

Trial Design Consulting Services

Read Analysis Services

Operational Imaging Services

By Applications

Pharmaceutical & Biotechnology Companies

Medical Device Manufacturers

Contract Research Organizations

Academic and Government Research Institutes

Global Clinical Trial Imaging Market: By Countries

United States,Canada,Germany,UK,France,Italy,Spain,Russia,China,Japan, South Korea,Australia,Thailand,Brazil,Argentina,Chile,South Africa,Egypt, UAE,Saudi Arabia

 Global Clinical Trial Imaging Market Overview

Medical imaging plays an active role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology and pharmaceutical industries continue to increase. This can be attributed to enhanced investment in medical imaging companies as well as mergers and acquisitions along with the adoption of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machinery and their installation and high capital required to run clinical trials can restrain the growth of the market.

 Get Discount on This Report: https://healthcaremarketreports.com/discount/clinical-trial-imaging-market/48/

 Clinical Trial Imaging Market Report Highlights

  • Based on service, project and data management services held the largest share in 2020 due to the growing requirement of data management and workflow for clinical trial imaging
  • Operational imaging services held a significant share in 2020. They include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT. CT scan modality is gaining popularity due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment
  • The others application segment held the largest share in 2020. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications
  • By end-use, CROs held the largest share in 2020 due to increasing investments in the field of research and development and snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time and patent expiration
  • North America dominated the market in 2020 due to the increasing geriatric population, rising chronic diseases, and growing demand for treatment options

About Us:

The healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.

Contact Us:

healthcare Market Reports

sales@healthcaremarketreports.com

+1(929)-450-2887

Leave a Reply

Your email address will not be published.

North Korea Will Soon Launch Multiple Satellites To Monitor Military Movements By U.S. And It Allies Previous post North Korea Will Soon Launch Multiple Satellites To Monitor Military Movements By U.S. And It Allies
Audiology Devices Market Next post Audiology Devices Market 2022 Trends, Standardization, Challenges Research, Key Players and Forecast to 2028